PCM
NARI

Peregrine Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Peregrine Capital Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-183,609
Closed -$9.37M – 345
2024
Q4 		$9.37M Buy
183,609
+3,280
+2% +$161K 0.28% 88
2024
Q3 		$7.44M Buy
180,329
+394
+0.2% +$18.9K 0.22% 119
2024
Q2 		$8.66M Buy
+179,935
New +$7.98M 0.25% 105

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Peregrine Capital Management's NARI Position: Q1 2025 in Review

Peregrine Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 183,609 shares — an estimated $9.37M sold.

Peregrine Capital Management first reported a position in NARI in Q2 2024 and held it in 3 quarters. The position peaked at $9.37M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Peregrine Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Peregrine Capital Management sold 183,609 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $9.37M.
  • Peregrine Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • Peregrine Capital Management's Inari Medical, Inc. Common Stock position peaked at $9.37M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Peregrine Capital Management's 13F filing for Q1 2025, filed 25 Apr 2025.